News

Odyssey Thera (Odyssey) has reported that it will receive milestone payments from one of its investors, Pfizer, following the latter’s decision to progress drug candidates studied by Odyssey

Zelos Therapeutics (Zelos) has initiated patient dosing in a single dose study of three proprietary subcutaneous formulations of ZT-034 (hPTH (1-34), teriparatide). ZT-034 is being developed to compete

DelSiTech has signed a collaboration agreement with Orion Corporation. The agreement enables Orion to apply DelSiTech drug delivery technology in combination with its drug molecules for different therapeutic

Cipher Pharmaceuticals (Cipher) has enrolled first patient in its phase III safety study of Cip-Isotretinoin, the company’s patented formulation of isotretinoin, used in the treatment of severe, nodular

Quest Diagnostics has revealed that it is performing DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting

Vical Incorporated’s TransVax cytomegalovirus (CMV) vaccine continued to demonstrate an overall increase in cellular immune responses compared with placebo, at the seven-month immunogenicity data point in an ongoing

Impax Laboratories has reached an agreement with Astellas Pharma and Boehringer Ingelheim to settle pending US litigation with regard to US Patent for Flomax capsules, through the entry

Aeolus Pharmaceuticals (Aeolus) has reported that AEOL 10150 protects lungs from whole mustard gas exposure in rats, based on the series of preliminary studies conducted by National Jewish

Angelini has received a letter from the FDA stating that it has appropriately addressed all deficiencies cited by the FDA, following its inspection of the manufacturing facility in